{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:12:58Z","timestamp":1788970378266,"version":"build-2803163510"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,9]]},"DOI":"10.1093\/jjco\/hyag075","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:41:55Z","timestamp":1776944515000},"page":"1152-1153","source":"Crossref","is-referenced-by-count":0,"title":["Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4952-6305","authenticated-orcid":false,"given":"Takeshi","family":"Takahashi","sequence":"first","affiliation":[{"name":"Health and Welfare Bureau, Kitakyushu City Office , Jyonai 1-1, Kitakyushu 803-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"2026090910433303300_ref1","doi-asserted-by":"publisher","first-page":"i87","DOI":"10.1093\/jjco\/hyaf021","article-title":"Trends in net survival for prostate cancer in Japan, 2000-14 (CONCORD-3)","volume":"56","author":"Tanaka","year":"2026","journal-title":"Jpn J Clin Oncol"},{"key":"2026090910433303300_ref2","doi-asserted-by":"publisher","first-page":"r1179","DOI":"10.1136\/bmj.r1179","article-title":"Prostate cancer: polygenic risk scores have not shown clinical benefit","volume":"10","author":"Lucassen","year":"2025","journal-title":"BMJ."},{"key":"2026090910433303300_ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-024-03804-w","article-title":"Determining the clinical significance of pathological findings in prostate cancer","author":"Takahashi","year":"2024","journal-title":"Virchows Arch"},{"key":"2026090910433303300_ref4","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"319","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA."},{"key":"2026090910433303300_ref5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"key":"2026090910433303300_ref6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"2026090910433303300_ref7","doi-asserted-by":"publisher","first-page":"d6395","DOI":"10.1136\/bmj.d6395","article-title":"Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes","volume":"13","author":"Penston","year":"2011","journal-title":"BMJ."},{"key":"2026090910433303300_ref8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ajog.2015.10.147","article-title":"Cervical cancer screening: evidence behind the guidelines","volume":"214","author":"Lees","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2026090910433303300_ref9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamainternmed.2017.0340","article-title":"Recent patterns of prostate-specific antigen testing for prostate cancer screening in the United States","volume":"177","author":"Fedewa","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026090910433303300_ref10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jjco\/hyp025","article-title":"The Japanese guideline for prostate cancer screening","volume":"39","author":"Hamashima","year":"2009","journal-title":"Jpn J Clin Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/9\/1152\/68293510\/hyag075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/9\/1152\/68293510\/hyag075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:31:48Z","timestamp":1788967908000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/9\/1152\/8678982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":10,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5,15]]},"published-print":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag075","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,5,15]]}}}